Bone Screw System Market is likely to grow at a CAGR of 6.4% through 2028, Analysis By Future Market Insights

Future Market Insights tracks the performance of the global bone screw system market in a new publication titled “Bone Screw System Market: Global Industry Analysis 2013 – 2021 and Opportunity Assessment 2022 – 2028”. The bone screw system market is anticipated to record a year-over-year growth rate of 6.5% and reach a market value of US$ 1,963 Mn in 2028. Titanium will continue to account for the leading market revenue share by Material Type, accounting for 45.0% share of the global bone screw system market in 2022. In this report, the bone screw system market is segmented based on material type, patient anatomy, end user and region.

Get a Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-4050

Bone Screw System Market: Segmental Insights

Lower extremity segment leads the market for bone screw system owing to increasing number of cases registered due to prolonged effects of osteoporosis among the mass population. In contrast, there are limited number of companies conducting research activities for introducing novel products in the market. In terms of revenues, the lower extremity segment is expected to account for the largest revenue share of 39.2% in 2022 and is expected to witness significant growth during the forecast period. This growth in the lower extremity segment is expected to be primarily driven by rising awareness among the geriatric population and increasing number of orthopaedic cases undergoing surgical interventions.

Stainless steel is likely to be the preferred choice of material used in common practice due to its ready availability and cost efficiency as compared to titanium based screws and bioabsorbable material. Titanium holds a major share in the global market currently due to widespread usage. The bioabsorbable material segment has limited adoption in the market due to premium pricing over other bone screw products.

Among end users, hospitals are expected to hold the maximum share in the overall bone screw system market due to the large number of surgical procedures performed in hospitals using bone screws as compared to other end users such as ambulatory surgical centres and clinics. The hospitals end user segment is estimated to hold a market share of 65.6% in 2022.

Bone Screw System Market: Trends

Computer assisted technology is a revolutionary concept used in orthopaedic treatment procedures. Companies are focussing on collaboration with all end users to develop new effective products with better user interfaces. They are involving breakthrough options in this market to initiate a sense of revolution in using more advanced alternatives. In 2016, Surgebright in cooperation with the German Institute for Tissue and Cell Replacement (DIZG) in Berlin developed latest technology that uses real bone material to form a screw. 3D printing is another innovative technology that could be used in developing bone screws in the near future.

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-gb-4050

Bone Screw System Market: Regional Insights

The report tracks the global bone screw system market across the key geographies of North America, Europe, Latin America, Asia Pacific Excluding China, China and Middle East & Africa. This report assesses the trends driving each regional market and offers analysis and insights about the bone screw system market across specific countries in the assessed regions. North America accounts for a major share in the global bone screw system market and is expected to grow at a CAGR of 7.1% during the period of assessment. North America is projected to be the most lucrative market in the global bone screw system market with an attractiveness index of 2.3 during the forecast period due to the presence of leading manufacturers and implementation of healthcare reforms in the region.

Bone Screw System Market: Competition Tracking

The key players operating in the bone screw system market include companies such as Stryker Corporation, Zimmer Biomet Holdings Inc, CONMED Corporation, Arthrex, Orthofix, SMITH & NEPHEW, Johnson & Johnson (DePuy Synthes), Integra LifeSciences, Wright Medical Group N.V, SURGIVAL INTERNATIONAL, Spineology Inc, GPC Medical ltd., Osteogenics Biomedical,  Altimed, JEIL MEDICAL CORPORATION, Fine Science Tools, MEIRA Inc. and Medtronic.

Have Any Questions Regarding Bone Screw System Market Report, Ask Our Experts@ https://www.futuremarketinsights.com/ask-question/rep-gb-4050

Key Segments Covered in Bone Screw System Industry Survey

Bone Screw System by Material Type

  • Stainless-Steel Bone Screw System
  • Titanium Screw Bone Screw System
  • Bio-absorbable Screw Bone Screw System

Bone Screw System by Application

  • Lower Extremity Bone Screw System
  • Upper Extremity Bone Screw System
  • Spinal Bone Screw System
  • Other Bone Screw Systems

Bone Screw System by End User

  • Bone Screw System for Hospitals
  • Bone Screw System for Clinics
  • Bone Screw System for Ambulatory Surgical Centers

Bone Screw System by Region

  • North America Bone Screw System Market
  • Latin America Bone Screw System Market
  • Europe Bone Screw System Market
  • South Asia & Pacific Bone Screw System Market
  • East Asia Bone Screw System Market
  • MEA Bone Screw System Market

To study the growth strategies of the top manufacturers of bone screw systems and to understand the current market structure, write to Future Market Insights analysts at press@futuremarketinsights.com

Biologic Excipients Market is expected to be valued at US$ 1,706.2 million by the end of 2028

Future Market Insights (FMI) delivers key insights on the global biologic excipients market in its upcoming report titled “Biologic Excipients Market: Global Industry Analysis 2013–2017 and Opportunity Assessment 2018 – 2028”. In terms of revenue, the global biologic excipients market is projected to register a CAGR of 3.6% over the forecast period owing to various factors, regarding which FMI offers detailed insights and forecasts in this report.

Global Biologic Excipients Market: Segmental Analysis & Forecast

The global market is segmented based on excipient type, end user and region. Based on excipient type the market is segmented into polymers, sugar alcohols, polysorbates, inorganic salts, amino acids, surfactants and others. Polymers biologic excipients are anticipated to lead the biologic excipients market over the forecast period. Polymer biologic excipients account for the highest revenue share and are anticipated to witness a growth rate of 3.7% over the forecast period.

By end user, the market is segmented into biopharmaceutical manufacturers, contract research organisations/contract manufacturing organisations, and research organisations. Biopharmaceutical manufacturers is the leading segment in the global biologic excipients market over the forecast period. This segment accounts for a relatively higher revenue share, which is expected to register a CAGR of 6.0% over the forecast period.

Get a Free Sample Copy of the Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-6982

Global Biologic Excipients Market: Dynamics

Growth of the global biologic excipients market is primarily driven by rising global demand for medicines, greater uptake of biologics driving demand for parenteral formulations, increasing acquisition of contract research organisations, patent expiration of major blockbuster drugs, growing adoption of advanced drug delivery technologies, increasing research in pediatric formulations, growing demand for extended-release or sustained release formulations, increasing demand for oral solid drug formulations, rising demand from emerging economies pushing local drug production, and increasing per capita healthcare expenditure.

However, lack of proper data documentation on gras status of excipients, regulatory audits restricting supply capacity, regulatory hurdles detering novel excipient development, and stability testing of excipients imposing cost liabilities on drug manufacturers are some factors expected to hamper the growth of the global biologic excipients market over the forecast period.

A key trend witnessed in the biologic excipients market is increasing adoption of continuous processing of biologic excipients, dependence of large drug manufacturers on in-house biologic excipients production, vast proportion of imported excipients leading to production delays, and regulatory harmonisation with respect to gradation of excipients. Furthermore, the growing importance of developing biologic excipients by big players in order to enhance their product portfolio, growing importance for manufacturing authorisation, growing market for topical and parenteral applications and compulsory licensing promoting demand for biologic excipients are the key trends likely to be witnessed in the global biologic excipients market.

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-gb-6982

Global Biologic Excipients Market: Regional Analysis

The North America regional market is projected to dominate the global biologic excipients market, accounting for a maximum revenue share of the global market by 2017 end. The North America, Western Europe, and Asia Pacific markets accounted for 77.3% of the total biologic excipients market share in terms of value in 2017. Revenue from the market in APEJ is estimated to expand at a CAGR of 4.2% over the forecast period.

Some of the key players featured in this report on the global biologic excipients market include BASF Corporation, FMC Corporation, Wacker Chemie AG, Evonik Industries AG, Ashland Global Holdings Inc., Archer-Daniels-Midland Co., Roquette Freres S.A., The Dow Chemical Company, Colorcon Inc., Signet Chemical Co. Pvt. Ltd. This report discusses the individual strategies followed by these companies regarding bringing improvements in their products, creating new manufacturing facilities, market consolidation and advanced R&D initiatives. The report concludes with key takeaways for players already present in the market and new players planning to enter the market.

Ask Us Your Questions About This Report: https://www.futuremarketinsights.com/ask-question/rep-gb-6982

Market segmentation

The global biologic excipients market is segmented on the basis of excipient type into:

  • Polymers
  • Sugar Alcohols
  • Polysorbates
  • Inorganic Salts
  • Amino Acids
  • Surfactants
  • Others

For more insights on the biologic excipients market, write to the analysts of Future Market Insights at press@futuremarketinsights.com

Behavioural Health Market is projected to expand at 3.4% CAGR over the forecast period of 2022-2028

According to the latest market report published by Future Market Insights titled “Behavioural Health Market: Global Industry Analysis 2013–2021 and Opportunity Assessment 2022–2028”, the global behavioural health market is expected to expand at 3.4% CAGR over the forecast period 2022-2028.

North America is expected to hold the highest revenue share in the global behavioural health market over the forecast period. Currently, over 43.8 million adults in the U.S. are suffering from mental illness, which is fuelling demand for behavioral health services. Developing economies are witnessing large demand for home care services, day care services, and internet-counselling services, which is further expected to boost revenue growth of the behavioural health market in emerging markets.

Download FREE Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-5375

Global Behavioural Health Market: Segmental Analysis & Forecast

The global behavioural health market is segmented based on service type, disorder type, and region. Based on service type the market is segmented into outpatient counselling, intensive case management, home-based treatment services, inpatient hospital treatment, emergency mental health service and others. The inpatient hospital treatment services type segment is expected to represent highest revenue share in the global behavioural health market. Home-based treatment services are expected to gain popularity among people in the coming years and this segment is expected to expand at a CAGR of 4.0% over the forecast period.

Based on disorder type the market is segmented into the anxiety disorder, bipolar disorder, depression, eating disorder, post-traumatic stress disorder (PSTD), substance abuse disorder and others. Among all disorder types, the anxiety disorder segment is anticipated to continue to lead the global behavioural health market due to a high patient pool globally and high adoption of behavioural health therapy among patients suffering from anxiety issues. According to the WHO, globally 260 million people are suffering from anxiety disorder.

Increased exposure to drugs and alcohol among young adults and strengthening insurance coverage policies for mental health are identified as key trends among end users in the global behavioural health market. Furthermore, rehabilitation programs for substance abuse disorder patients, outpatient counselling for ADHD affected children, and campaigns to spread awareness regarding mental disorders and drug addiction, etc. are some of the major factors that are driving the growth of the global behavioural health market. Government initiatives to reduce the burden of mental illness and rehabilitation services by non-government organizations (NGO) are further expected to positively impact revenue growth of the global behavioural health market.

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-gb-5375

Global Behavioural Health Market: Competition Analysis

The global market for behavioural health is fragmented with many local and regional level players operating in the worldwide market. Some of the key players featured in the global behavioural health market report include Acadia Healthcare Co., Inc., Universal Health Services Inc., Magellan Health Inc., National Mentor Holdings Inc., Behavioral Health Services Inc., Behavioral Health Network Inc., North Range Behavioral Health, Strategic Behavioral Health LLC, Seton Healthcare Family (Ascension Health) and Ocean Mental Health Services Inc. etc. among others.

Feel free to ask your queries at https://www.futuremarketinsights.com/ask-question/rep-gb-5375

Key Segments Covered in Behavioural Health Industry Survey

Behavioural Health by Service Type

  • Outpatient Counselling for Behavioural Health
  • Intensive Case Management for Behavioural Health
  • Home-based Treatment Services for Behavioural Health
  • Inpatient Hospital Treatment for Behavioural Health
  • Emergency Mental Health Service for Behavioural Health
  • Others

Behavioural Health by Disorder Type

  • Anxiety Disorder
  • ADHD
  • Bipolar Disorders
  • Depression
  • Eating Disorder
  • Post-traumatic Stress Disorder (PTSD)
  • Substance Abuse Disorder
  • Others

Behavioural Health Market by Region

  • North America Behavioural Health Market
  • Latin America Behavioural Health Market
  • Europe Behavioural Health Market
  • East Asia Behavioural Health Market
  • South Asia & Pacific Behavioural Health Market
  • Middle East & Africa (MEA) Behavioural Health Market

For more insights on the global market for behavioural health, write in to Future Market Insights analysts at press@futuremarketinsights.com

Stroke Assistive Devices Market Current Scenario Trends, Comprehensive Analysis and Regional Forecast to 2028

An assistive device, commonly, is a medical equipment that assists a disabled person or patients having inability to perform their daily tasks due to acute stroke or traumatic disorders. When a person encounters acute stroke, it becomes difficult for that patient to recover immediately from after effects of acute stroke that represents reduced mobility in limbs and extreme difficulties in performing their daily tasks such as dressing, bathing, grooming, cooking, feeding, etc. Thus, after having a stroke or trauma, most of the patients require assistive devices in order to maximize their independent functioning. In general, assistive devices find major applications for the disease indications including stroke, orthopedic, cognitive and motor skills, sports and others.

One of the most commonly used assistive device prescribed for stroke survivors is Mobility Assistive Devices (MAD). These mobility assistive devices for stroke patients offer improved mobility and allows them to independently perform the mobility-related tasks. A person who encountered stroke often has to undergo a long rehabilitation. Financed by the EU Research and Innovation programme Horizon H2020, robot-based technologies have been under substantial use to speed up the rehabilitation of stroke patients under its project called “the RETRAINER”. The technology used under this project allows the stroke patients to utilize their own arms and hands, as much and as soon, after the trauma or post-stroke in order to achieve best results in the rehabilitation.

After encountering stroke, a person usually goes to the physiotherapist for treatment or post-stroke recovery. The treatment may go wrong if the physiotherapist is not trained well, however, a patient receives quality treatment if these orthopedic treatment procedures are performed using robotic assistive devices. Stroke assistive devices are highly utilized in rehabilitation process to treat a physically disabled person in order to improve their daily performance. Thus, with the emergence of high incidence for stroke and trauma cases, stroke assistive devices experience greater demand from the end customers. Thus generating large revenues in the stroke assistive devices market.

Stroke assistive devices market on the basis of device type is classified into two main types – robotic exoskeletons, stroke-rehabilitation gloves, and others. Stroke rehabilitation is a treatment process solely targeted towards restoration of intellectual, physical, mental and social capabilities of a patient affected by stroke.

The growing incidence of stroke in U.S. population tends to be the leading reason to propel the growth of stroke assistive devices market across the globe. The growing adoption of stroke assistive devices by the physicians to treat post stroke effects is further anticipated to drive the demand for stroke assistive devices and thereby increasing revenue generation in stroke assistive devices market.

Request Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-6921

Stroke Assistive Devices: Market Dynamics

Growing innovation and funding in neuromuscular & stroke rehabilitation, availability of high-tech and effective stroke assistive devices such as wearable wirelessly controlled rehabilitation device in the market, and growing population of stroke patients owing to increasing incidence of neuromuscular disorders and stroke across the globe is expected to be the key factor driving growth of stroke assistive devices market.

Rapid increase in physical disabilities caused due to increasing prevalence of disorders including spinal cord injury, rheumatoid arthritis, cerebral palsy and additional ageing disabilities is further expected to surge the demand for robotic rehabilitation and stroke-assistive technologies. Thus, the demand for stroke assistive devices has registered an upsurge, thereby generating more revenues in stroke assistive devices market. Also, growing mergers and acquisitions among the leading players in order to increase their geographical footprint is another factor propelling the growth of stroke assistive devices market.

However, lack of awareness among the people about new robotic technologies to assist stroke affected patient, particularly in the emerging economies, coupled with high cost of assistive technologies and robotic rehabilitation are some of the factors restraining the stroke assistive devices market growth.

Request Report Methodology: https://www.futuremarketinsights.com/askus/rep-gb-6921

Stroke Assistive Devices Market: Overview

Based on device type, robotic devices including robotic exoskeletons and stroke-rehabilitation gloves register the highest demand in the stroke assistive devices market owing to the better mobility results registered with usage of this device as compared to others. Stroke assistive devices found major usage in management of acute stroke and chronic neuromuscular disorders such as Multiple Sclerosis, Guillain Barre Syndrome, Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Cerebral Palsy, and Muscular Dystrophy.

Rising number of disabled people due to the above mentioned disorders is one of the major factor driving the demand for stroke assistive devices for early management of patients effected with stroke, thereby fueling the stroke assistive devices market across the globe. However, the growing footprint of stroke assistive devices manufacturers for chronic disorders management applications coupled with rising demand for these devices is further expected to drive the revenue generation in global stroke assistive devices market.

Stroke Assistive Devices Market: Region-wise Outlook

On the basis of geography, global stroke assistive devices market is segmented into seven key regions viz. North America, Latin America, Western Europe, Eastern Europe, Asia Pacific excluding Japan, Japan, and Middle East & Africa. Europe is projected to hold largest shares in the global stroke assistive devices market primarily due to increasing prevalence of disabilities in the region owing to growing incidence of stroke and neuromuscular disorders, enhanced healthcare infrastructure and increased R&D expenditure for manufacturing stroke-assistive devices. In Russia, about 13 million people are registered to live with certain post-stroke disabilities, constituting around 9% of the total Russian population. North America followed by Western Europe is expected to be the second dominating region in global stroke assistive devices market worldwide.

Stroke Assistive Devices Market: Key Players

Some of the key players present in global stroke assistive devices market are AnthroTronix, Inc., ReWalk Robotics, Mazor Robotics Ltd., Intuitive Surgical Inc., Interactive Motion Technologies, Bioxtreme Robotics Rehabilitation, Accuray, Inc., Health Robotics S.R.L., Ekso Bionics Holdings, Inc., and others.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.

Get Customization in the Report, Enquire Now @ https://www.futuremarketinsights.com/customization-available/rep-gb-6921

Stroke Assistive Devices Market: Segmentation

The global stroke assistive devices market is segmented by device type and end user:

Segmentation by Device Type

  • Mobility Devices
  • Wheelchairs
  • Mobility Scooters
  • Walkers and Rollators
  • Cranes and Crutches
  • Transfer Lifts
  • Others
  • Robotic Aids
  • Robotic Exoskeletons
  • Stroke-Rehabilitation Gloves
  • Robotic Gait Trainers
  • Medical and Bathroom Assistive Devices
  • Shower Chairs and Tub Benches
  • Toilet Seats and Bedside Commodes
  • Other Bathing/Dressing Aids
  • Ostomy Products
  • Medical Beds
  • Reading and Vision Aids
  • Hearing Devices

Segmentation by End User

  • Hospitals
  • Specialty Clinics
  • Physiotherapy Centers
  • Ambulatory Surgical Centers
  • Home Care Settings
  • Others

Global Boron Trifluoride & Complexes Market Is Projected To Grow At A CAGR Of ~ 5% During The Forecast Period Of 2019-2029

The global boron trifluoride & complexes market sales are anticipated to be valued at ~US$ 233 Mn by the end of 2019, witnessing a strong Y-O-Y growth of ~4.5% over the year 2018, finds a recent study published by Future Market Insights. Asia Pacific excluding Japan is projected to hold more than half of the market value share by end of 2019 and grow with a significant CAGR in the near future, opines the study.

Get | Download Sample Copy with Graphs & List of Figures:
https://www.futuremarketinsights.com/reports/sample/rep-gb-4067

Boron trifluoride is amongst the strongest Lewis acids (electron pair acceptor), and therefore, it finds application as a catalyst for a number of organic synthesis reactions including polymerization, alkylation, isomerization, and other chemical synthesis reactions.

A number of polymer derivatives are being made in the presence of boron trifluoride as a catalyst such as polypropylene and polyethylene. Boron trifluoride gas and its complexes are also being used for manufacturing rubber and other elastomeric polymers, which are increasingly being used across a number of end-use industries. Moreover, boron trifluoride is also used for the synthesis of different range of hydrocarbons such as aromatic hydrocarbons, unsaturated hydrocarbons, alcohols, phenols, and many others.

With growth in oil and gas and petrochemical industries in the region, through shale gas extraction, there has been tremendous growth in hydrocarbons synthesis and other chemicals, which use BF3 as a major catalyst during reaction. This, in turn, is driving the demand for boron trifluoride & complexes in the market, opines the FMI study.

The study also finds that the demand for boron trifluoride (BF3) gas and di ethyl etherate are anticipated to grow with significant CAGRs in terms of value during the forecast period. Furthermore, the applications of boron trifluoride & complexes as catalysts are projected to grow with a healthy CAGR owing to the huge demand generated from synthetic reactions such as polymerization, alkylation, isomerization, and other chemical synthesis.

For More Information or Query or Customization Before Buying, Visit:
https://www.futuremarketinsights.com/customization-available/rep-gb-4067

Stringent Regulations on Manufacturing of Boron Trifluoride & Complexes Could Hinder Growth

Boron trifluoride, especially in the gaseous form, is considered to be a hazardous, toxic, and very corrosive substance. Therefore, there are a number of regulations pertaining to its manufacturing, transportation, labelling, exposure limit, labelling, and others.

Packaging and transportation of the gas is done under extremely high pressure and is a major challenge for manufacturers, distributors, and end users as well. Moreover, for using boron trifluoride in the gaseous form, there must be an appropriate unloading facility at the consumers’ end, which is leading to many of the end users using boron trifluoride in the complexes form. This factor is estimated to hinder the global boron trifluoride market by the end of the forecast period.

For any queries linked with the report, ask an analyst
https://www.futuremarketinsights.com/ask-question/rep-gb-4067

Boron Trifluoride & Complexes Market: Vendor Insights

The boron trifluoride & complexes market is fairly fragmented due to the presence of manufacturers at the regional level. Few of them included in the global boron trifluoride & complexes market report are – BASF SE, Air Liquide, Praxair Technology, Inc., Honeywell International Inc., Matheson Tri-Gas Inc., Gulbrandsen, Entegris, Inc., The Linde Group, Stella Chemifa Corporation, Hunan Heaven Materials Development Co., Arkema, ZIbo Shuanglian Petroleum & Chemical Co., Ltd., NAVIN FLUORINE INTERNATIONAL LIMITED, Qingzhou Chenkai Chemical Co., Ltd., ZIbo Shuanglian Petroleum & Chemical Co., Ltd., and Tanfac Industries Ltd.

Companies are focusing on mergers and acquisitions of big and small players in the market for expansion of sales and to gain competitive leverage over other players. For instance, in October 2016, the Honeywell International Inc. acquired the Research Chemicals Business from Sigma-Aldrich. The acquisition enabled the company to offer a broad line of inorganic chemicals and solvents for demanding applications.

Plant-Based Milk To Increase At 8.8% CAGR Between 2021 And 2031

Popularity of vegan diets can be attributed to popularity of veganism and rising focus on sustainable living. As per Future Market Insights (FMI), these factors will create conducive environment for the expansion of the plant based milk market. The report also forecasts the sales of plant-based milk to increase at 8.8% CAGR between 2021 and 2031.

Get | Download Sample Copy with Graphs & List of Figures:
https://www.futuremarketinsights.com/reports/sample/rep-gb-13818

Concerns about the humane treatment of animals have also had a significant influence in the gradual shift toward vegan diets. The market for plant-based milk is predicted to expand as a result of these factors.

Consumers have become more appreciative of and inclined toward plant-based products, such as juices and other plant-based beverages, as health and wellness concerns have grown, due to the rise in prevalence of obesity, diabetes, and cardiovascular diseases.

Plant-based goods contribute to healthy eating habits by providing higher nutritional content, vitamins, minerals, and healthy fats. Veganism is gradually becoming more popular. Some of the countries have been identified to represent the trend from the fore at global forums. For instance:

  • In 2016, Singapore earned the spot of second-most vegan friendly Asian city by PETA Asia. Singapore was also titled the top 6th vegan city in the world by Happy Cow.
  • Hong Kong was listed in the top 10 vegan friendly countries by Peta Asia in 2020. According to a vegan business platform, Eco Warrior Princess, roughly 25% -70% of Hong Kong residents consume vegan meals.
  • Thailand witnessed the launch of several vegan restaurants and food outlets recently such as Veganerie, Vistro, May Veggie Home, and Swees among others.

For More Information or Query or Customization Before Buying, Visit:
https://www.futuremarketinsights.com/customization-available/rep-gb-13818

Key Takeaways from the Plant-based Milk Market Study:

  • The U.S. is estimated to account for more than 80% of the North America market in 2021, supported by consumer awareness regarding nutritional foods.
  • According to FMI’s analysis, China is estimated to account for more than 60% of the Asia Pacific market in 2021, supported by easy availability of raw materials.
  • The U.K. is a high potential market in Europe, accounting for over 9.4% value share, supported by the popularity of clean label trends.
  • Sales via online retail are expected to grow at 10.8% CAGR through 2031.

“Consumers across the globe are becoming increasingly health-conscious. Increasing focus on health and wellness have been drawing them towards plant-based milk in comparison to regular diary. This also is encouraging the market players to put greater emphasis on product launches,” said a lead analyst at FMI. 

For any queries linked with the report, ask an analyst
https://www.futuremarketinsights.com/ask-question/rep-gb-13818

Sustainability of Plant-based Milk Production to Increase its Appeal

Plant-based milk is popular among customers because of benefits it provides in terms of sustainability, nutrition, and convenience. Consumers now demand food & beverages that are good for both their bodies and environment.

There are various concerns with conventional dairy products, including inhumane livestock rearing & addition of pesticides and chemicals to dairy milk, among others. Because of its vegan origins and branding as a health product, demand for plant based milk such as oat milk is likely to increase.

Who is winning?

Manufacturers of plant-based milk are trying to attract customers by packaging their products in cartons which are creatively and beautifully crafted. It helps plant-based milk producers differentiate their beverage from the rest and draws more customers as buyers choose to purchase a more visually appealing product compared to a typical product.

Some of the leading companies offering plant-based milk are Groupe Danone, Alpina Foods, Blue Diamond Growers, Inc., Döhler GmbH, Earth’s Own Food Company Inc, Elden Foods Inc, Freedom Foods Group Ltd, Goya Foods, Groupe Danone, Hain Celestial Group, Inc, Kaslink Foods Oy Ltd, Living Harvest Foods Inc, Liwayway Holdings Company Limited, Mc Cormick & Co., Natura Foods, Nutriops SL, Organic Valley, Pacific Foods of Oregon, Inc, and others.

Varicella Zoster Infection Treatment Market Size 2022 Global Key Findings, Industry Demand, Regional Analysis, Key Players Profiles, Future Prospects and Forecasts to 2028

The global Varicella Zoster Infection Treatment Market in 2020 is estimated for more than US$ 1.5 Bn and expected to reach a value of US$ 2.0 Bn by 2028 with a significant CAGR of 4.1%. As per Future Market Insights’ projections, in 2022, the acyclovir holds a substantial share of over 55.7% in the overall varicella zoster infection treatment market.

Human alphaherpesvirus 3, also known as Varicella Zoster virus (VZV) is one of the many herpesviruses that is known to infect humans.  It is also the one causing infectious diseases like chicken pox (which is mostly common among children and teens) and herpes zoster (shingles) (mostly affecting adults but rarely in children).  The growing incidence of herpes zoster (shingles) infection among the children’s and the elderly and the rising demand towards the treatment of the infection is aiding the growth of the market.

Request a Sample Report with Table of Contents and Figures: https://www.futuremarketinsights.com/reports/sample/rep-gb-6466

For instance, in December 2016, Slayback and Sandoz signed an agreement with Novartis AG for the sale and marketing rights of Slayback Generic Zovirax Ointment (Acyclovir Ointment). Per the agreement Novartis obtained the sales and marketing rights, which increased their position in the market. Other leading companies operating in the market are Valeant Pharmaceuticals International Inc., Teva Pharmaceutical Industries Ltd, Pfizer Inc., Mylan N.V., Abbott Laboratories, GlaxoSmithKline Plc., and Dr. Reddy’s Laboratories Ltd., among others.

According to the report, the global varicella zoster infection treatment market is expected to register a 4.2% CAGR from 2017 to 2027. In 2016, the market was worth US$ 1,257.1 Mn and is expected to reach a valuation of US$ 1,969.1 Mn by the end of 2027.

Risk of Varicella in Pregnancy and the Need to Adhere to the Guidelines of Chickenpox Treatment to Bode Well for the Market 

Primary infection with varicella zoster in pregnancy may cause maternal mortality or serious morbidity issues. A particular guideline issued in 2015 assesses the evidence regarding maternal and foetal risks of varicella zoster virus infection in pregnancy. The U.K. Advisory Group and Swiss and Canadian national guidelines prescribe procedures for the use of antiviral drugs in pregnancy. The U.K. Advisory Group provides guidelines for chickenpox as well. These guidelines recommend oral acyclovir, which should be prescribed for pregnant women within 24 hours once they present the onset of the rash and if they have 20+0 weeks of gestation or beyond. Guidelines are unanimous nevertheless, in recommending that intravenous acyclovir be administered in cases of severe maternal infection. This factor along with the fact that the rate of exposure and transmission is extremely high in this infection and is a threat for pregnant women and kids, is expected to boost the growth of the varicella zoster infection treatment market.

Our advisory services are aimed at helping you with specific, customised insights that are relevant to your specific challenges. Let us know about your challenges and our trusted advisors will connect with you: https://www.futuremarketinsights.com/askus/rep-gb-6466

Natural Products to Challenge Market Growth

Several people opt for other treatment options for herpes zoster and varicella. These alternative treatment options are expected to hamper the growth of the antiviral drugs market for varicella zoster infection treatment. Homeopathy, supplements, and other natural herbal medicines are used to treat herpes zoster and varicella.

Table Of Content

1. Executive Summary

2. Market Introduction

3. Varicella Zoster Infection Treatment Market Opportunity Analysis 

4. Market Background

5. Global Economic Outlook

6. Key Inclusions

Ask for TOC @ https://www.futuremarketinsights.com/toc/rep-gb-6466

Contact Us:                                                      

Future Market Insights
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Automated Blood Processing Equipment Market Competitive Growth Strategies Based on Type, Applications, End User and Region

Automated blood processing equipment is used for the blood collection and processing of whole blood sample. The primary use of whole blood is as a source material for the preparation of blood components such as RBC (red blood cells), WBC (White blood cells), platelets, plasma and others components. The automated blood processing equipment helps to convert whole blood into different blood components, which are mostly used for the blood transfusion and others purposes.

Get | Download Sample Copy with Graphs & List of Figures:
https://www.futuremarketinsights.com/reports/sample/rep-gb-6712

Reduced human intervention with minimal contamination chances and shorten the duration of blood processing by reducing processing steps are the key benefits of the automated blood processing equipment. Hospitals and blood banks focus on to optimize throughput without increasing lab burden, expedite patient care and enhance laboratory efficiency through automated blood processing equipment. Automated blood processing equipment provides efficient outcomes, which facilitate diagnosis and treatment, reduce emergency room times with faster and reliable results than the traditional blood processing equipment.

Technology Advancement

Blood transfusion procedure can be helpful in various life-threating situations such as an accident or surgery, cancer therapy and disease (leukemia, myeloma, etc.). Manual collection and processing of whole blood should be carried out taking safety measures, but that would be time-consuming and contamination prone process. The main advantage of automated blood processing equipment include reduction of a number of equipment involved in blood component separation processing, overcome the laborious steps and standardize the quality of blood component. Healthcare facilities are more interested in automated blood processing equipment due to compact characteristics that lead to the reduction of workspace and increases production efficiency.

For More Information or Query or Customization Before Buying, Visit:
https://www.futuremarketinsights.com/customization-available/rep-gb-6712

Rise in demand of safe and enhanced quality of blood components, increasing incidence of chronic diseases, strong campaigning for blood donation programs and growing healthcare spending are the key factors that drive the market growth over the forecast period. Technological advancements and development in donation screening test kits also play a vital role in the increasing demand for automated blood processing equipment. Changes in blood collection procedure and gradual migration of manual blood processing to automated processing machine are all poised to benefit the market growth. Also, the top manufacturers in the market are expanding the value chain to forward integrate the market in developing economies. In most of the developed countries, increasing investment in terms of healthcare spending and investment in healthcare facilities by government authorities are impelling the demand for automated blood processing equipment.

Regional Market Outlook

North America leads the automated blood processing equipment market owing to developed healthcare infrastructure, support from the government, and availability of advanced blood collection facilities. Western Europe is the second leading market for automated blood processing equipment due to increasing blood donation centers and blood transfusion sites that propel the demand. Increase in chronic diseases and surgical procedural volumes are also the leading factors that have raised the demand for pathogen-free blood and its components, which further increase the demand for automated blood processing equipment. The Asia Pacific excluding China and Japan market is also expected to grow at a higher rate owing to improving healthcare spending on capital equipment for enhancing automation in facilities and large target patient pool.

For any queries linked with the report, ask an analyst
https://www.futuremarketinsights.com/ask-question/rep-gb-6712

Competition Outlook

Some of the players identified in the global automated blood processing equipment market are Beckman Coulter, Inc, Fresenius Kabi AG, Terumo Corporation, Immucor, Macopharma., Grifol, and Others. The companies are focusing on innovating their automated blood processing equipment in order to reduce their manufacturing costs and compete in the market with reduced prices. Companies are opting for mergers and acquisitions as their growth strategy for expanding their geographic presence.

Small-Scale Manufacturers/Providers

  • Immucor
  • JMS Singapore Pte Ltd
  • MOELCA
  • LMB Technologie GmbH
  • Delcon SRL.

Medium-Scale Manufacturers/Providers

  • Baxter Healthcare
  • Macopharma
  • Grifols

Large-Scale Manufacturers/Providers

  • Beckman Coulter, Inc
  • Fresenius Kabi AG
  • Terumo Corporation

Key Data Points Covered in the Report

The report covers exhaustive analysis on:

  • Automated Blood Processing Equipment Market by product type, end-user and region
  • Regional level market analysis of North America, Latin America, Western Europe, Asia Pacific Excluding China & Japan, Japan, Middle East & Africa by product type, end-use segments and country
  • Automated Blood Processing Equipment Market Dynamics & Opportunity Assessment
  • Historical Actual Market Size, 2013 – 2017
  • Automated Blood Processing Equipment Market Size & Forecast 2018-2028
  • Automated Blood Processing Equipment Market Current Trends/Issues/Challenges
  • Competition & Companies involved

Research Methodology

The market sizing of automated blood processing equipment will be done by the installed-based triangulation approach. The demand-side approach will be followed to assess the actual market size of automated blood processing equipment. Secondary research will be used in the initial phase to identify the feasibility of the target services and its respective segments in end-use facilities and the future impact of new technologies. Each piece of information will be eventually analyzed during the entire research project, which helps build a strong base for the primary research information.

Primary research participants include demand-side respondents such as laboratory managers, procurement managers, hospitals, blood bank as well as key opinion leaders in addition to supply-side respondents such as equipment manufacturers who provide valuable insights on trends, research application of products and technologies, purchasing patterns, services offered and associated pricing.

Herpes Labialis Treatment Market 2022 by Global Key Players, Types, Applications, Countries, Industry Size and Forecast to 2028

The global Herpes Labialis Treatment Market is expected to register a CAGR of nearly 4.7% over the forecast period (2022-2028) owing to increasing cases of recurrent herpes simplex infections. The herpes labialis treatment market recorded sales worth U.S. $ 1.03 Bn in the year 2021 and is expected to reach U.S. $ 1.42 Bn by the year 2028, according to the Future Market Insights (FMI) study.

The herpes labialis treatment market accounts for nearly 2% of the market share by value of the overall Antiviral Drugs Market, which was valued at nearly US$ 52.7 Bn in the year 2020. The herpes labialis treatment market experienced an increase in the demand in the past few year owing to the rising prevalence of herpes labialis infections around the world. Herpes labialis is caused by herpes simplex virus (HSV), which primarily affects the lips and are alternatively called as cold sores. According to the World Health Organization’s 2020 statistics, approximately 3.7 million people suffered from HSV 1 infection globally.

To know key findings Request Sample Report @: https://www.futuremarketinsights.com/reports/sample/rep-gb-6461

North America to Maintain Leading Regional Market Position

Supported by strong presence of a few of the key industry players, North America’s herpes labialis treatment market is expected to continue its dominance throughout the forecast period. While this region registered over 35% value share, Western Europe recorded a share of over 20% in 2017. North American region is presumed to exceed the revenues worth US$ 450 Mn by the end of 2027, observing a declining CAGR of 3.9%. Although the US will lead the North American region, Future Market Insights projects that Canada will witness higher adoption of herpes labialis treatment in the assessment period.

On the flipside, emerging regional markets such as APEJ, MEA, Eastern Europe, and Latin America will see rapid growth in the forecast period. APEJ is identified to be the fastest growing market at a promising CAGR of 5.7%, followed by MEA, predicted to grow at 5.3% CAGR over 2017-2027. Strengthening efforts and accelerating investments in the examination of the clinical efficacy of drugs, increasing expenditure on R&D infrastructure, growing consumer awareness, and development of advanced, cost-effective treatment options at a rapid pace, will collectively lift the market in emerging countries up. Moreover, lenient FDI policies that govern the pharmaceuticals industry in developing economies prompt at the inflow of a series of opportunities for drug companies to explore these regional markets in near future.

Request for Report customization @: https://www.futuremarketinsights.com/customization-available/rep-gb-6461

Key Market Players

Some of the leading players competing in the global herpes labialis treatment market include Novartis AG, Valeant Pharmaceuticals International Inc., Pfizer Inc., Abbott Laboratories, Mylan NV, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., and GlaxoSmithKline plc. A majority of key players are directing their efforts towards extension of existing product portfolio, while others are focusing on strategic mergers and acquisitions in order to grab larger market shares in terms of revenue. Many top brands are looking forward to capitalize on growing opportunities in emerging regional markets.

Functional Films Market Is Poised To Reach US$ 47.17 Mn By 2031

As per a study by Future Market Insights (FMI), increasing applications across diverse sectors, especially the printing and packaging industry will drive the functional films market between 2021 and 2032. Functional films are being steadily commercialized across various industries as they incorporate technologies to improve the functional performance of products on which functional films acts as substrate or a barrier.

Get | Download Sample Copy with Graphs & List of Figures:
https://www.futuremarketinsights.com/reports/sample/rep-gb-603

The market is gaining momentum, thanks to the expansion of the packaging and plastic industries. Their usage across automotive also is increasing. Functional films can be spotted in automotive displays, car interiors, transmission systems, and lighting.  In the packaging sector, BOPP films are the “go-to” options for lamination and flexible packaging purposes.

As per FMI, the functional films market is poised to reach US$ 47.17 Mn by 2031. The demand for both optical and coating films is considerably high. Of these, coatings films are expected to emerge dominant, exhibiting 8.7% CAGR over the forecast period.

For More Information or Query or Customization Before Buying, Visit:
https://www.futuremarketinsights.com/customization-available/rep-gb-603

Key Takeaways of Functional Films Market Study

  • Application across various industries will continue driving functional films market at .2% CAGR through 2031
  • The U.S. remains the leading functional films market in North America, accounting for over 68% sales in 2021
  • After an insignificant year in 2020, the U.K. market will bounce back, registering a little below 6% y-o-y growth in 2021
  • Germany and France will remain key markets. Of these, Germany will remain dominant through the forecast period
  • Exceptional growth is likely in Japan, as it continues registering expansion of various end-use industries

“Functional films market, like any other sector, is heavily reliant on prevailing trends. Currently, there is high focus on sustainability especially as some of the leading players invest in environment-positive technologies,” said a lead analyst at FMI.

East Asia is expected to dominate the functional films global market. The intense activities in the region have stimulated market participants to engage in product innovations and steadily commercialize their products. In East Asia, the large demand owned by various end-use industries including consumer electronics and automotive, is likely favorable to mold the Functional Films market. The market growth is also dependent on various other factors such as raw material availability and large consumption base.

For any queries linked with the report, ask an analyst
https://www.futuremarketinsights.com/ask-question/rep-gb-603

Who is Winning?

Some of the leading companies operating in the functional films market include 3M, Dai Nippon Printing Co. Ltd, Toray industries Inc, SABIC, Covestro AG and Saint Gobain Films.

The functional films market is a highly competitive market dominated global petrochemical and chemical manufacturers and key players who are actively involved in the printing and packaging sector.  Some players are adopting backward integration, directly purchasing petrochemicals and manufacturing films from scratch. The market is also driven by regional players and new entrants who are aggressively involved to build their brand name.

The Tier-1 players hold approximately half the global value share. Drive for product positioning and collaboration are some of the common behavioral trends in the global market.

There is increasing focus on sustainability, especially some of the leading players. For instance, Coveris has built two new extrusion lines at Cheshire-based facility in Winsford, in the U.K. This capacity expansion is intended at supporting the company’s goal to achieve pack positive sustainability.